INBS logo

Intelligent Bio Solutions Inc. Stock Price

NasdaqCM:INBS Community·US$7.2m Market Cap
  • 1 Narratives written by author
  • 4 Comments on narratives written by author
  • 71 Fair Values set on narratives written by author

INBS Share Price Performance

US$0.72
-0.80 (-52.86%)
US$2.98
Fair Value
US$0.72
-0.80 (-52.86%)
76.0% undervalued intrinsic discount
US$2.98
Fair Value
Price US$0.72
Jolt_Communications US$2.98

INBS Community Narratives

Jolt_Communications·
Fair Value US$2.98 76.0% undervalued intrinsic discount

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

10users have liked this narrative
4users have commented on this narrative
62users have followed this narrative

Snowflake Analysis

Medium-low risk with mediocre balance sheet.

6 Risks
0 Rewards

Intelligent Bio Solutions Inc. Key Details

US$3.1m

Revenue

US$1.8m

Cost of Revenue

US$1.2m

Gross Profit

US$11.8m

Other Expenses

-US$10.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.16
40.85%
-346.23%
7.0%
View Full Analysis

About INBS

Founded
2016
Employees
54
CEO
Harry Simeonidis
WebsiteView website
ibs.inc

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Recent INBS News & Updates

Recent updates

No updates